UPDATED: #Canada #SARSCoV2 variants.
Of 132 samples from 11/17 - 11/23:
XEC.*: 34.9% ( 27.9% of 1026; 24.8% of 1426)
KP.3.1.1.* (incl. MC.1): 56.8% ( 61%; 62.6%)
MC.1: 12.9% ( 11.6%; 11.6%)
https://anarchodelphis.tumblr.com/CanadaVariants #COVID19
----------
Of the samples collected in Canada on these weeks, the prevalence of each of these significant variants/lineages are as follows:
- 11/17 - 11/23 -
• XEC.*: 34.9%
• JN.1.11.1.* †: 59.1%
→ KP.3.* (incl. KP.3.1.*, ".3.3.*, MC.1): 59.1%
→ KP.3.1.1.* (incl. MC.1): 56.8%
→ MC.1: 12.9%
† 1 KP.1.1.3 and 1 KP.2.2 sample counted as JN.1.*
- 11/10 - 11/16 -
• XEC.*: 27.9%
• JN.1.11.1.*: 67%
→ KP.3.* (only KP.3.1.1, ".3.3.*, MC.1 counted) §: 63.5%
→ KP.3.1.1.* (incl. MC.1): 61%
→ MC.1: 11.6%
§ Other KP.3.*, MK.1 combined fell below 2% threshold; counted as JN.1.11.1.*
X.X.* in text denotes variant X.X and its descendants.
X.X.* in the graph includes all descendants of strain X.X, except for ones that have their own segment of the week’s bar.